Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel phthalazine-based protein kinase inhibitors in Pharmacia pipeline

March 28, 2003

New series of PDE10A inhibitors with utility in cancer identified at Bayer

March 28, 2003

Antitumor polyketides prepared and tested at Novartis

March 28, 2003

Novartis patents new antitumor tyrosine kinase inhibitors

March 28, 2003

Progress on three fronts in OGS/Medarex alliance

March 27, 2003

CPMP recommends approval of Busulfex in Europe

March 27, 2003

Enrollment under way in pivotal trial of T-67 in hepatocellular carcinoma

March 27, 2003

Italian researchers identify novel antitumor taxanes

March 27, 2003

NIH licensing a class of gp100 cancer antigens

March 26, 2003

GTI-2040 awarded orphan drug status for renal cell cancer

March 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...